Search results
Results: 78
Number of items: 78
-
Steuten, J., Bos, A. V., Kuijper, L. H., Claireaux, M., Olijhoek, W., Elias, G., Duurland, M. C., Jorritsma, T., Marsman, C., Paul, A. G. A., Garcia Vallejo, J. J., van Gils, M. J., Wieske, L., Kuijpers, T. W., Eftimov, F., van Ham, S. M., ten Brinke, A., & T2B Consortium (2023). Distinct dynamics of antigen-specific induction and differentiation of different CD11c+Tbet+ B-cell subsets. Journal of Allergy and Clinical Immunology, 152(3), 689-699.e6. https://doi.org/10.1016/j.jaci.2023.02.020 -
Wieske, L., Takkenberg, R. B., Tas, S. W., Bemelman, F. J., ten Brinke, A., Verstegen, N. J. M., van Ham, S. M., & T2B! immunity against SARS-CoV-2 study group (2022). Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases. BMC Medicine, 20, Article 100. https://doi.org/10.1186/s12916-022-02310-7
-
te Brinke, L. W., Schuiringa, H. D., Menting, A. T. A., Deković, M., Westera, J. J., & de Castro, B. O. (2022). Treatment approach and sequence effects in cognitive behavioral therapy targeting emotion regulation among adolescents with externalizing problems and intellectual disabilities. Cognitive Therapy and Research, 46(2), 302-318. https://doi.org/10.1007/s10608-021-10261-1
-
Marsman, C., Verstegen, N. J. M., Streutker, M., Jorritsma, T., Boon, L., Ten Brinke, A., & van Ham, S. M. (2022). Termination of CD40L co-stimulation promotes human B cell differentiation into antibody-secreting cells. European journal of immunology, 52(10), 1662-1675. https://doi.org/10.1002/eji.202249972
-
van Kempen, Z. L. E., Wieske, L., Stalman, E. W., Kummer, L. Y. L., van Dam, P. J., Volkers, A. G., Boekel, L., Toorop, A. A., Strijbis, E. M. M., Tas, S. W., Wolbink, G. J., Löwenberg, M., van Sandt, C., ten Brinke, A., Verstegen, N. J. M., Steenhuis, M., Kuijpers, T. W., van Ham, S. M., Rispens, T., ... T2B! immunity against SARS-CoV-2 study group (2022). Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: To wait and repopulate? Multiple sclerosis and related disorders, 57, Article 103416. https://doi.org/10.1016/j.msard.2021.103416
-
Marsman, C., Verhoeven, D., Koers, J., Rispens, T., ten Brinke, A., van Ham, S. M., Kuijpers, T. W., & T2B Consortium (2022). Optimized Protocols for In-Vitro T-Cell-Dependent and T-Cell-Independent Activation for B-Cell Differentiation Studies Using Limited Cells. Frontiers in Immunology, 13, Article 815449. https://doi.org/10.3389/fimmu.2022.815449
-
Koers, J., Marsman, C., Steuten, J., Tol, S., Derksen, N. I. L., ten Brinke, A., van Ham, S., & Rispens, T. (2022). Oxygen level is a critical regulator of human B cell differentiation and IgG class switch recombination. Frontiers in Immunology, 13, Article 1082154. https://doi.org/10.3389/fimmu.2022.1082154
-
van den Dijssel, J., Hagen, R. R., de Jongh, R., Steenhuis, M., Rispens, T., Geerdes, D. M., Mok, J. Y., Kragten, A. H. M., Duurland, M. C., Verstegen, N. J. M., van Ham, S. M., van Esch, W. J. E., van Gisbergen, K. P. J. M., Hombrink, P., ten Brinke, A., & van de Sandt, C. E. (2022). Parallel detection of SARS-CoV-2 epitopes reveals dynamic immunodominance profiles of CD8+ T memory cells in convalescent COVID-19 donors. Clinical & translational immunology, 11(10), Article e1423. https://doi.org/10.1002/cti2.1423
-
Palomares Cabeza, V., Kummer, L. Y. L., Wieske, L., Hagen, R. R., Duurland, M., Konijn, V. A. L., van Dam, K. P. J., Stalman, E. W., van de Sandt, C. E., Boekel, L., Verstegen, N. J. M., Steenhuis, M., Rispens, T., Tas, S. W., Wolbink, G., Killestein, J., Kuijpers, T. W., van Ham, S. M., Eftimov, F., ... Target-to-B! (T2B!) SARS-CoV-2 study group (2022). Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod. Neurology® Neuroimmunology & Neuroinflammation, 9(4), Article e1178. https://doi.org/10.1212/NXI.0000000000001178
Page 4 of 8